Intravenous Immunoglobulin Therapy in Autoimmune Mucocutaneous Blistering Diseases: A Review of the Evidence for its Efficacy and Safety

Author： Gürcan Hakan M. Jeph Sunil Ahmed A. Razzaque

Publisher： Adis International

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.11, Iss.5, 2010-10, pp. : 315-326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Intravenous Immunoglobulin for Immune-Mediated Skin Disease: Current View

By Ruetter A. Luger T.A.

American Journal of Clinical Dermatology, Vol. 5, Iss. 3, 2004-01 ,pp. : 153-160

Adis International

Access to resources Recommend Favorite

Mechanisms of Intravenous Immunoglobulin Action in the Treatment of Autoimmune Disorders

By Larroche C.

BioDrugs, Vol. 16, Iss. 1, 2002-01 ,pp. : 47-55

Adis International

Access to resources Recommend Favorite

Intravenous Immunoglobulin Plus Interferon- in Autoimmune Hepatitis C

By Malaguarnera M.

BioDrugs, Vol. 18, Iss. 1, 2004-01 ,pp. : 63-70

Adis International

Access to resources Recommend Favorite

Dapsone 5% Gel: A Review of its Efficacy and Safety in the Treatment of Acne Vulgaris

By Stotland Mira

American Journal of Clinical Dermatology, Vol. 10, Iss. 4, 2009-06 ,pp. : 221-227

Adis International

Access to resources Recommend Favorite

Variations in Serum Hemoglobin, Albumin, and Electrolytes in Patients Receiving Intravenous Immunoglobulin Therapy: A Real Clinical Threat?

By Mignogna Michele D.

American Journal of Clinical Dermatology, Vol. 8, Iss. 5, 2007-01 ,pp. : 291-299

Adis International

Access to resources Recommend Favorite